Evolving Therapeutic Scenario of Stage III Non-Small-Cell Lung Cancer.
Lung cancer remains the leading cause of cancer-related death with an incidence that continues to increase in both sexes and all ages. However, 80% to 90% of lung cancers are non-small cell lung cancer (NSCLC) and the remaining 10% to 20% are small cell lung cancer. Adenocarcinoma is the most common...
| Publicado en: | Clinical Medicine Insights: Oncology pp. 1 - 11 |
|---|---|
| Autores principales: | , , |
| Formato: | algorithm research tables/charts Journal Article |
| Publicado: |
Sage Publications Inc.
2/14/2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |